Background-Colonic strictures repre-
The gastrointestinal manifestations of cystic fibrosis are characterised by malabsorption leading to steatorrhoea, flatulence, and abdominal pain. In addition to pancreatic insufficiency, small bowel mucosal dysfunction has been recognised as a contributing factor.' Biochemical studies have disclosed dysfunction of the intestinal Cl-transporter,2 abnormal secretion of mucus, 3 and enhanced intestinal uptake of some nutrients (glucose, alanine).4 These alterations may account for some of the well known gastrointestinal complications in cystic fibrosis, such as meconium ileus and distal intestinal obstruction syndrome. Among disorders associated with cystic fibrosis, Crohn's disease is 17 times more common than in the general population.5
Recently, colonic strictures requiring resection were described in a series of boys with cystic fibrosis. Subsequently, other cases were added."'3 Although the lesions seemed to be related to the introduction of high strength pancreatic enzyme supplements,6 14 their aetiology remains to be established. Histological features, such as extensive submucosal fibrosis and mild chronic inflammatory infiltrate, do not resemble previously described strictures, induced either by ingestion of potassium chloride preparations or non-steroidal antiinflammatory drugs, which are characterised by ulceration.5 16 The term "fibrosing colonopathy" was introduced to describe this new type of gastrointestinal complication in cystic fibrosis, involving a prestricture state with varying degrees of stenosis, as well as true colonic strictures.17 The second can be diagnosed by barium enema, endoscopy, and biopsy.9 13 18 19 By contrast, the detection of prestricture lesions remains a diagnostic problem, because there are no valid data available on presenting features in these patients, or risk factors for development of colonic strictures.
Recently, we described pronounced colonic wall thickening in a girl with cystic fibrosis detected by ultrasound who had, after meconium ileus, several attacks of distal intestinal obstruction syndrome before starting high strength pancreatic enzyme supplementa-20 tion. However, at presentation the girl had only few symptoms and the clinical importance of our ultrasound findings remained unclear. It is possible that this bowel wall thickening reflected the prestricture state of fibrosing colonopathy.
Participating in a multicentre prospective study, we investigated a series of patients with cystic fibrosis and healthy control subjects. The aim was to evaluate frequency of sonographic bowel wall thickening in cystic fibrosis, during clinical evaluation and follow up.
Methods

Subjects
In this prospective study, we investigated 90 patients with cystic fibrosis (45 females) with a mean age of 1 1 9 (SD 9) (median 9 8; range below 2 g/day in patients younger than six years of age, and below 7 g/day in patients older than six years of age was considered normal.24 The patients were taking in normal amounts of fat (900/o of recommended daily allowance). Statistics Student's t test, multivariate analysis of variance (MANOVA), and multivariate regression were used to analyse the results after logarithmic transformation of bowel wall measurements. Table III summarises the ultrasound measurements. In controls, maximum thickness of the wall of the small intestine was 1-5 mm and maximum thickness of the colon wall was 1-9 mm. There was a slight, but significant (r=-0594; p<0-001) increase with age (Fig 2) . In cystic fibrosis, bowel wall thickness of both small intestine and colon was significantly (p<0-0001) higher than in controls (Fig 3) ; 81% of patients with cystic fibrosis had a maximum colon wall thickness at any site of 2 mm or more, and 46% of patients had ileum wall thickness of 1-5 mm or more. Bowel wall thickening of more than 2 mm involving the entire colon was noted in 19% of patients. Maximum wall thickness reached 6-5 mm at the ascending colon in one patient. As in controls, there was a slight but significant (r=0-193; p<0Q001) increase in wall thickness with age (Fig 2) . Figure 1 shows representative ultrasound scans of bowel wall thickening of varying degrees. Bowel wall thickening in cystic fibrosis was mainly due to increased thickness of the submucosa, whereas the mucosa and muscularis remained unchanged (Fig 1) . In cystic fibrosis and in controls there was no peristalsis to disturb colon wall measurements. Small amounts of free peritoneal fluid were found in 24 (28%) patients, whereas no fluid was detected in any of the controls.
Results
At re-examination after one year, there was no significant change in median wall thickness in 72 We did not find any association between bowel wall thickening and previous meconium ileus, resection, distal intestinal obstruction syndrome, or abdominal pain. There was, however, a significant (r=-0261, p<005) positive correlation between increased stool fat excretion and increased caecal wall thickness. For pancreatic enzyme supplementation, bowel wall thickness did not correlate with enzyme preparation, protease dose, lipase dose, dosage group, or lifetime dosage (Fig 4) .
In the four patients who produced sufficient pancreatic enzyme, maximum wall thickness of the ileum and the colon was 1P4 mm and 3 mm respectively. Asymptomatic intussusception was detected in five patients. Two patients with ileoileal intussusception had ileum wall thickness of 1P3 and 1 6 mm; three patients with ileocaecal intussusception had ileum wall thickness between 1-5 and 2 mm and caecum wall thickness between 3-6 and 3 9 mm.
Discussion
Ultrasound examination is a widely used noninvasive method for the evaluation of Crohn's disease, ulcerative colitis, and coeliac disease. [24] [25] [26] [27] [28] In recent years, the development of high resolution ultrasound transducers has facilitated identification of the different layers of the bowel wall. Ultrasound examination has therefore provided a means of detecting mucosal changes and bowel wall thickening, and has supplemented conventional diagnostic methods of barium enema and endoscopy.9 22 In the present ultrasound study, we found considerable colonic wall thickening in 81% of patients with cystic fibrosis. A similar finding was reported by MacSweeney et al'4 who described colonic wall thickening in 51% of patients with cystic fibrosis. However, in their study, the maximum colon wall thickness of controls was 0O8 mm. This value differed considerably from our control cut off value of 2-0 mm, and was also much lower compared with earlier studies (2 to 3 mm). Evaluation of the small intestine disclosed ileum wall thickening in 46% of our patients with cystic fibrosis. It is possible that this may be related to recurrent asymptomatic intussusception, which may occur more often than assumed so far (60/o in our series). Terminal ileal involvement (with submucosal fibrosis) was also described in several cases of fibrosing colonopathy.8 29 30 In the absence of confirmatory histology, any correlation with our findings remains speculative.
Our ultrasound data showed no correlation between bowel wall thickness and history of meconium ileus or intestinal resection. This confirmed results by MacSweeney et al. '4 In addition, we could not detect a correlation between bowel wall thickness and previous distal intestinal obstruction syndrome. In the course of our study two patients developed this syndrome, requiring surgical lavage in one. In both cases, the colonic wall was only moderately thickened. These data suggest that distal intestinal obstruction syndrome was not related to bowel wall thickening.
We We conclude that submucosal bowel wall thickening is a common feature in patients with cystic fibrosis, which seems unrelated to various clinical factors and supplementation. Ultrasound examination was a reliable noninvasive method for evaluating this intestinal involvement in cystic fibrosis. As pancreatic enzyme dosage was obviously not correlated with bowel wall thickening, recommendations on changes in pancreatic supplementation seem premature. Further studies are necessary to determine the natural history of fibrosing colonopathy and to detect risk factors for colonic strictures. Until these are understood, it would seem unnecessary to harm patients by inducing steatorrhoea with insufficient pancreatic supplementation.
